M.I. Medical Incentive

Company Overview

Snapshot

Founded in July 2012 by Daniel Levin, M.I. Medical Incentive operates with 1–10 employees. The company is focused on developing noninvasive cardiovascular diagnostic and monitoring tools, with its product currently in the clinical trial stage.

Business overview

M.I. Medical Incentive is a digital health startup specializing in the development of medical cardiovascular wearable devices. The company's core technology provides a 15-minute automated test designed for diagnosing and monitoring heart failure in patients and high-risk groups. Operating within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Devices, M.I. Medical Incentive serves a broad market including hospitals, clinics, healthcare providers, doctors, patients, seniors, and insurance companies, with a focus on global reach.

Company Intelligence Q&A

What is M.I. Medical Incentive's primary focus?

M.I. Medical Incentive is focused on developing noninvasive cardiovascular diagnostic and monitoring tools, specifically a medical cardiovascular wearable device for heart failure patients and high-risk groups.

Who are the founders of M.I. Medical Incentive?

M.I. Medical Incentive was co-founded by Daniel Levin.

What markets does M.I. Medical Incentive target?

M.I. Medical Incentive targets a global market, serving healthcare providers, hospitals, clinics, doctors, patients, seniors, and insurance companies.

What is the core technology offered by M.I. Medical Incentive?

The company's technology enables a 15-minute automated test for diagnosing and monitoring heart failure, delivered through a medical cardiovascular wearable device.